# Use of Transmucosal Ketamine in Post Stroke Depression

> **NCT04876066** · PHASE1 · UNKNOWN · sponsor: **West Virginia University** · enrollment: 21 (estimated)

## Conditions studied

- Post-stroke Depression

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT04876066
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-30
- **Primary completion:** 2022-11
- **Final completion:** 2022-11
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04876066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04876066, "Use of Transmucosal Ketamine in Post Stroke Depression". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04876066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*